Britons with a debilitating bowel disease may be spared life-changing surgery thanks to a drug used to treat the flaky skin condition psoriasis.Health chiefs have now approved risankizumab for patients with hard-to-treat Crohn’s disease.The drug works by blocking immune cells that drive the serious bowel damage caused by Crohn’s, and offers a much-needed option for hundreds of patients who don’t respond to current treatments.
Load More
Load More